Bacsan, Liam F.
HRN: 21-87-60 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/03/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/03/2022
09/09/2022
IV
52mg
OD
Neonatal Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes